Chiesi Pharma AB: public contracts won without a rival in Denmark: 5 uncontested awards; 45% of its awards; 0 without a competition; 5 single bid.
Assay record ASY-DK-0FDTAE10FS · Cite as: Assay Systems, “Chiesi Pharma AB: public contracts won without a rival in Denmark”, https://assay-systems.com/register/dk/uncontested/s/chiesi-pharma-ab/
Chiesi Pharma AB won 5 of its 11 public contract awards in Denmark without a rival from 2024-04-15 to 2026-08-17: 0 without a competition and 5 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Amgros I/S with 5.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Amgros I/S gave Chiesi Pharma AB 11 awards: 0 without a competition, 5 after a competition with a single bid. First 2024-04-15, latest 2026-08-17.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2026-08-17 | Amgros I/S 566842-2026 | Single bid open | — |
| 2025-12-12 | Amgros I/S 828216-2025 | Single bid open | — |
| 2025-02-19 | Amgros I/S 110468-2025 | Single bid open | — |
| 2024-11-26 | Amgros I/S 719658-2024 | Single bid open | — |
| 2024-04-15 | Amgros I/S 221192-2024 | Single bid open | — |
Every uncontested award in Denmark · All countries · Chiesi Pharma AB in the register
Source: Tenders Electronic Daily (TED), Publications Office of the European Union, contract award notices. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.